drugset / Trial / NCT00206323

A Randomized, Placebo-controlled, Tourette Syndrome Study.

NCT00206323

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Previous studies using topiramate in Tourette subjects have shown that with the use of this medication subjects report that their tics get better. The purpose of this study is to study if topiramate improves the symptoms of Tourette syndrome, such as motor tics, or other associated symptoms such as attention or obsessive-compulsive problems.

Timeline

Start
2004-09
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Topiramate Small molecule 200 mg

Indications